Legend Biotech Corp LEGN

Latest FY: 2025 Healthcare Biotechnology
Market Price $21.76
Market Cap $8.05B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑64.0% YoY
$1.03B
3-Yr CAGR: 100.5%
Net Income ↓-59.6% YoY
-$282.60M
Net Margin: -27.5%
Free Cash Flow ↓-102.8% YoY
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-28.2%
ROA: -16.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LEGN)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2019: Revenue YoY (+16.5%) is identical to Gross Profit YoY (+16.5%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
  • FY 2020: Revenue YoY (+32.2%) is identical to Gross Profit YoY (+32.2%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
  • FY 2021: Revenue YoY (-9.1%) is identical to Gross Profit YoY (-9.1%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017
FY 2018 $49.1M $27.1M $-1.6M
FY 2019 $57.3M +16.5% $31.6M $-133.0M -8,128.5% $-15.4M $-54.1M
FY 2020 $75.7M +32.2% $41.7M $-303.5M -128.2% 0.00% $-7.4M $-53.1M +1.7%
FY 2021 $68.8M -9.1% $37.9M $-403.6M -33.0% 0.00% $-0.6M $-44.5M +16.3%
FY 2022 $127.7M +85.6% $51.6M $-446.3M -10.6% 0.00% $-3.7M $-24.6M +44.6%
FY 2023 $285.1M +123.3% $140.9M $-518.3M -16.1% 0.00% $-1.0M $-21.1M +14.5%
FY 2024 $627.2M +120.0% $392.7M $-177.0M +65.8% 0.00% $-14.1M +33.0%
FY 2025 $1,028.9M +64.0% $620.8M $-282.6M -59.6% 0.00% $-28.6M -102.8%
$

Valuation

Market Price $21.76
Market Cap $8.05B
Enterprise Value $7.33B
P/E Ratio N/A
P/B Ratio 8.03
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 369,886,369
%

Profitability & Margins

Gross Margin 60.34%
Operating Margin -13.27%
Net Margin -27.47%
Return on Equity (ROE) -28.20%
Return on Assets (ROA) -16.30%
Asset Turnover 0.59x
Revenue 3-Yr CAGR 100.47%
🛡️

Financial Health & Liquidity

Current Ratio 1.96
Cash Ratio 1.42
Debt / Equity 0.181
Debt / Assets 0.105
Cash & Equivalents $901.90M
Total Debt $181.80M
Book Value / Share $2.71
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $28.60M
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $2.71
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.73B
Total Liabilities $731.60M
Stockholders' Equity $1.00B
Current Assets $1.25B
Current Liabilities $636.40M